CJC-1295 (no DAC) vs Tesamorelin
CJC-1295 (no DAC) and Tesamorelin are both stocked here and are often considered together. This page sets out what differs between them: their class, the sizes and price per milligram, the shape of the published evidence behind each, and where each stands under Canadian law. It does not rank them, because which is appropriate depends on what is being studied.
Side by side
| CJC-1295 (no DAC) | Tesamorelin | |
|---|---|---|
| Class | Growth hormone-releasing hormone (GHRH) analogue | Growth hormone-releasing hormone (GHRH) analogue |
| Sizes and price | 10 mg — from $38.00 (best $3.80/mg) | 5 mg · 10 mg — from $61.50 (best $8.55/mg) |
| Published evidence | 6 cited studies; 1 controlled trial in people. | 8 cited studies; 8 controlled trials in people. |
| Models studied | rat, rat anterior pituitary membranes, in vitro structure-activity study of hgrf-nh2 analogues | human |
| Status in Canada | No Drug Identification Number; named in a Health Canada advisory | Ingredient is in an authorized Canadian medicine (a different product) |
| Formats | vial, starter | vial, starter |
Key differences
CJC-1295 (no DAC) 6 cited studies; 1 controlled trial in people. Tesamorelin 8 cited studies; 8 controlled trials in people.
No published study has compared CJC-1295 (no DAC) and Tesamorelin directly. Everything above is drawn from separate studies of each compound, so the two columns are not results from one experiment.
Both are supplied for in-vitro laboratory research only and neither is for human or veterinary use.
FAQ
What is the difference between CJC-1295 (no DAC) and Tesamorelin?
CJC-1295 (no DAC) is growth hormone-releasing hormone (ghrh) analogue; Tesamorelin is growth hormone-releasing hormone (ghrh) analogue. The table above sets out the sizes, the price per milligram, the evidence behind each and their Canadian status.
Which has more published research, CJC-1295 (no DAC) or Tesamorelin?
CJC-1295 (no DAC) has 6 cited studies on its page and Tesamorelin has 8. Study count is not quality: the model each one used matters more, and both pages list that for every paper.
Are CJC-1295 (no DAC) and Tesamorelin authorized in Canada?
No Drug Identification Number; named in a Health Canada advisory for CJC-1295 (no DAC). Ingredient is in an authorized Canadian medicine (a different product) for Tesamorelin. Health Canada authorizes a drug by issuing an eight-digit Drug Identification Number, and most research peptides have none.
Can CJC-1295 (no DAC) and Tesamorelin be used together?
No published study has tested them in combination, so there is no evidence about what a pairing does. We supply both for laboratory research and make no claim about using them together.